Enterically coated cysteamine, cystamine and derivatives thereof

  • US 9,925,158 B2
  • Filed: 07/21/2017
  • Issued: 03/27/2018
  • Est. Priority Date: 01/27/2006
  • Status: Active Grant
First Claim
Patent Images

1. A dosage form comprising enterically-coated granules having a core comprising cysteamine bitartrate and cystamine or a pharmaceutically-acceptable salt thereof;

  • at least one pharmaceutically acceptable binder; and

    an enteric coating surrounding the core, wherein the enterically-coated granules release cysteamine and cystamine or a pharmaceutically-acceptable salt thereof at a pH of 4.5-6.5.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×